By
Sam Wightwick2025-11-04T09:16:07
A newly developed peptide, WRPRFa, is giving scientists a clearer view of how the acid-sensing ion channel (ASIC3) drives pain signalling.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-12T09:31:00Z
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2023-05-03T15:39:23
Sponsored by BPS Bioscience
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2023-04-04T15:03:09
Sponsored by Agilent
2023-05-10T11:18:16
Sponsored by Revvity
Site powered by Webvision Cloud